BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11025711)

  • 1. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
    Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
    J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
    Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
    J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of 2001 Partin tables in Turkey: a multicenter study.
    Eskicorapci SY; Karabulut E; Türkeri L; Baltaci S; Cal C; Toktas G; Akpinar H; Ozer G; Sozen S; Tokuc R; Lekili M; Soylu A; Albayrak S; Sahin H; Alpar R; Ozen H
    Eur Urol; 2005 Feb; 47(2):185-9. PubMed ID: 15661412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction of prostate cancer in China.
    Gao X; Ren S; Lu X; Xu C; Sun Y
    Urology; 2008 Nov; 72(5):1096-101. PubMed ID: 18822453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
    Penson DF; Grossfeld GD; Li YP; Henning JM; Lubeck DP; Carroll PR
    J Urol; 2002 Apr; 167(4):1653-7; discussion 1657-8. PubMed ID: 11912382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
    Augustin H; Eggert T; Wenske S; Karakiewicz PI; Palisaar J; Daghofer F; Huland H; Graefen M
    J Urol; 2004 Jan; 171(1):177-81. PubMed ID: 14665871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
    Steuber T; Karakiewicz PI; Augustin H; Erbersdobler A; Lange I; Haese A; Chun KH; Walz J; Graefen M; Huland H
    J Urol; 2005 Mar; 173(3):737-41. PubMed ID: 15711259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
    Bhojani N; Ahyai S; Graefen M; Capitanio U; Suardi N; Shariat SF; Jeldres C; Erbersdobler A; Schlomm T; Haese A; Steuber T; Heinzer H; Montorsi F; Huland H; Karakiewicz PI
    Eur J Surg Oncol; 2009 Feb; 35(2):123-8. PubMed ID: 18786800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
    Zorn KC; Capitanio U; Jeldres C; Arjane P; Perrotte P; Shariat SF; Lee DI; Shalhav AL; Zagaja GP; Shikanov SA; Gofrit ON; Thong AE; Albala DM; Sun L; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1461-7. PubMed ID: 18938046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
    Veltri RW; Miller MC; Mangold LA; O'Dowd GJ; Epstein JI; Partin AW
    J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the updated Partin tables in a cohort of North American men.
    Karakiewicz PI; Bhojani N; Capitanio U; Reuther AM; Suardi N; Jeldres C; Pharand D; Péloquin F; Perrotte P; Shariat SF; Klein EA
    J Urol; 2008 Sep; 180(3):898-902; discussion 902-3. PubMed ID: 18635222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: a population based study.
    Borque A; Sanz G; Allepuz C; Plaza L; Gil P; Rioja LA
    J Urol; 2001 Nov; 166(5):1672-8. PubMed ID: 11586200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.
    Graefen M; Haese A; Pichlmeier U; Hammerer PG; Noldus J; Butz K; Erbersdobler A; Henke RP; Michl U; Fernandez S; Huland H
    J Urol; 2001 Mar; 165(3):857-63. PubMed ID: 11176486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the updated partin tables in a cohort of French and Italian men.
    Bhojani N; Salomon L; Capitanio U; Suardi N; Shariat SF; Jeldres C; Zini L; Pharand D; Péloquin F; Arjane P; Abbou CC; De La Taille A; Montorsi F; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):347-52. PubMed ID: 19004573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.